---
title: Does metacognitive therapy help women with PMDD reduce dysfunctional thinking?
description: Yes, metacognitive therapy reduced dysfunctions in women with PMDD. The therapy accounted for approximately 24.3% of the improvement in dysfunctional attitude
url: https://niyora.com/research/papers/the-effectiveness-of-metacognitive-therapy-on-dysfunctionalities-in-women-with-2024/
---

- [Niyora](https://niyora.com/)
- [Research](https://niyora.com/research/)
- [Library](https://niyora.com/research/library/)
- Does metacognitive therapy help women with PMDD reduce dysfunctional thinking?

Non-randomised trial, 2024

# Does metacognitive therapy help women with PMDD reduce dysfunctional thinking?

Yes, metacognitive therapy reduced dysfunctions in women with PMDD. The therapy accounted for approximately 24.3% of the improvement in dysfunctional attitudes.

 Moderate study design

30 female dentistry students with PMDD

## What they did

Quasi-experimental study with 30 female dentistry students diagnosed with PMDD. The treatment group received 12 weekly sessions of metacognitive therapy lasting 60 minutes each. A control group was placed on a waiting list. Dysfunctional attitudes were measured before treatment, after treatment, and at follow-up using a standard scale.

## What they found

Metacognitive therapy was effective in reducing dysfunctional attitudes. Approximately 24.3% of the improvement in dysfunctions was attributable to the therapy based on statistical analysis.

## What it means for you

Metacognitive therapy, which helps people change unhelpful thinking patterns, may reduce psychological problems in women with PMDD. However, the sample was small and selected through convenience sampling, so results may not generalize broadly.

30

women studied

12

therapy sessions

24.3%

variance in improvement attributable to therapy

## About the study

Original title The Effectiveness of Metacognitive Therapy on Dysfunctionalities in Women with Premenstrual Dysphoric Disorder Authors Houri Derakhshan Roudsari Year 2024 Study design Non-randomised trial Participants 30 What was tested Metacognitive therapy in 12 weekly sessions of 60 minutes each versus waiting list control Open access Yes Read the paper [doi.org/10.61838/kman.aftj.5.1.15](https://doi.org/10.61838/kman.aftj.5.1.15)

## Topics

[Premenstrual dysphoric disorder (PMDD)](https://niyora.com/research/topics/condition-pmdd/)[Low mood and depression](https://niyora.com/research/topics/symptom-depression-mood/)[Cognition, concentration and memory](https://niyora.com/research/topics/symptom-cognition/)[Cognitive behavioral therapy](https://niyora.com/research/topics/treatment-cbt/)[Students and academic performance](https://niyora.com/research/topics/life-area-education/)

Research tells you what helps on average. Niyora helps on the day it hits.

Calm down, see it another way, and decide what to say, with a PMS and PMDD app built by a doctor.

## Related studies

Randomised trial, 2026

Which works better for PMDD: cognitive-behavioral therapy or mindfulness-based cognitive therapy?

Randomised trial, 2023

What does research show about PMDD neurochemistry?

Review, 2024

What are the most effective treatments for PMDD?

Randomised trial, 2019

Does online cognitive behavioral therapy help women with PMDD?

Review, 2017

What causes PMDD and what are the best treatments?

Systematic review, 2016

What are the best treatments for PMDD without other mental health conditions?

Ask AI about this page

Copy prompt

ChatGPT

↗

Claude

↗

Perplexity

↗

Google AI Mode

↗

Grok

↗